Racine IVF Unit, Genetic Institute, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Fertil Steril. 2010 Aug;94(3):869-74. doi: 10.1016/j.fertnstert.2009.04.047. Epub 2009 May 29.
To assess ovarian response among carriers of FMR1 premutation who undergo preimplantation genetic diagnosis (PGD).
Retrospective study.
Academic IVF unit.
PATIENT(S): Of 18 carriers of FMR1 premutation referred to PGD, eight had <100 CGG repeats and ten had >or=100 CGG repeats.
INTERVENTION(S): Controlled ovarian stimulation (COH) and PGD.
MAIN OUTCOME MEASURE(S): Correlation between the number of CGG repeats and the level of E2 at day of hCG administration, number of retrieved oocytes, number of two-pronuclear (2PN) zygotes, and dose of recombinant FSH.
RESULT(S): There was a positive correlation between CGG repeats and the level of E2 at day of hCG administration, number of retrieved oocytes, and number of 2PN zygotes. There was a negative correlation between number of CGG repeats and the total dose of gonadotropins. The E2 level and the number of retrieved oocytes and 2PN zygotes were significantly higher and the dose of gonadotropins significantly lower for premutation patients with >or=100 CGG repeats compared with <100 CGG repeats.
CONCLUSION(S): There is a positive correlation between E2 level, retrieved oocytes, 2PN zygotes, and number of CGG repeats. Premutation carriers with <100 CGG repeats suffer from impaired ovarian response and decreased fertilization rate.
评估进行胚胎植入前遗传学诊断(PGD)的脆性 X 智力低下 1 基因(FMR1)前突变携带者的卵巢反应。
回顾性研究。
学术体外受精(IVF)单位。
18 名 FMR1 前突变携带者中,有 8 名携带 <100 个 CGG 重复,10 名携带 >or=100 个 CGG 重复。
控制性卵巢刺激(COH)和 PGD。
CGG 重复数与 hCG 给药日 E2 水平、获卵数、两原核(2PN)受精卵数和重组促卵泡激素(rFSH)剂量之间的相关性。
CGG 重复数与 hCG 给药日 E2 水平、获卵数和 2PN 受精卵数呈正相关。CGG 重复数与促性腺激素总量呈负相关。与 <100 个 CGG 重复的前突变携带者相比,>or=100 个 CGG 重复的前突变携带者的 E2 水平、获卵数和 2PN 受精卵数显著更高,而促性腺激素剂量显著更低。
E2 水平、获卵数、2PN 受精卵数与 CGG 重复数呈正相关。携带 <100 个 CGG 重复的前突变携带者卵巢反应受损,受精率降低。